Biotest AG BIOTEST ORD SHS/ DE0005227201 /
- - | Chg. - | Volume | Bid6:00:05 AM | Ask6:00:05 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 2.43 bill.EUR | - | 12.81 |
Assets
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 521.9000 | 522.2000 | 524.7000 | 520.3000 | 522.4000 | ||||||
Intangible Assets | 13.8000 | 14 | 11.3000 | 9.2000 | 9 | ||||||
Long-Term Investments | 7.6000 | .2000 | 5.6000 | 5.1000 | 11.3000 | ||||||
Fixed Assets | 585.6000 | 575 | 582 | 583.6000 | 654.4000 | ||||||
Inventories | 280.1000 | 290.1000 | 244.6000 | 293.8000 | 419.1000 | ||||||
Accounts Receivable | 107.7000 | 115.8000 | 107.3000 | 124.5000 | 145.2000 | ||||||
Cash and Cash Equivalents | 60.8000 | 71.3000 | 104.4000 | 116.6000 | 108.1000 | ||||||
Current Assets | 522.8000 | 556.3000 | 522.2000 | 619.4000 | 756.5000 | ||||||
Total Assets | 1,108.4000 | 1,131.3000 | 1,104.2000 | 1,203 | 1,410.9000 |
Liabilities
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 52.2000 | 42 | 38.8000 | 51.1000 | 78.1000 | ||||||
Long-term debt | 402.9000 | 462.5000 | 496.4000 | 612.8000 | 429.7000 | ||||||
Liabilities to Banks | 410.4000 | 470.4000 | 531.2000 | - | - | ||||||
Provisions | 28.9000 | 29.4000 | 25 | 115.2000 | 120.1000 | ||||||
Liabilities | 631.5000 | 689.7000 | 723.8000 | 831.9000 | 912 | ||||||
Share Capital | 39.6000 | 39.6000 | 39.6000 | - | - | ||||||
Total Equity | 476.9000 | 441.6000 | 380.4000 | 371.1000 | 498.9000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 1,108.4000 | 1,131.3000 | 1,104.2000 | 1,203 | 1,410.9000 |
Income Statement
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 419.1000 | 484.2000 | 515.6000 | 516.1000 | 684.6000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -1.2000 | -1.3000 | -47.1000 | -16.6000 | 143.5000 | ||||||
Interest Income | -10.5000 | -28.2000 | -16.8000 | -13.2000 | -40 | ||||||
Income Before Taxes | -1.3000 | -30 | -62.6000 | -30.8000 | 106.3000 | ||||||
Income Taxes | 3.4000 | 1.4000 | .7000 | -.8000 | 20.7000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -4.7000 | -31.4000 | -63.4000 | -31.7000 | 127 |
Per Share
Cash Flow
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -33.6000 | -16.7000 | 33.9000 | -40.5000 | -2.7000 | ||||||
Cash Flow from Investing Activities | -8 | -14.6000 | -23.4000 | -37 | 1.3000 | ||||||
Cash Flow from Financing | 40.5000 | 42 | 22.6000 | 89.6000 | -6.8000 | ||||||
Decrease / Increase in Cash | -1.1000 | 10.7000 | 33.1000 | - | - | ||||||
Employees | 1,837 | 1,928 | 1,967 | 2,228 | 2,426 |